Press Releases
-
Sep 4, 2019Co-promotion nearly doubles Tuzistra XR sales force ...Aug 5, 2019ZolpiMist Clinical Study Results Demonstrating Lingual Spray Delivers More Rapid Sleep Onset Compared to Tablet Form of Zolpidem Based on Efficacy Parameters and Pharmacokinetics...Aug 1, 2019Natesto Spermatogenesis Study Data Readout Set for October 16, 2019...Jul 30, 2019Acerus to Launch U.S. Specialty Sales Force; Nearly Doubles Natesto Sales Force ...Jul 24, 2019ENGLEWOOD, CO / ACCESSWIRE / July 24, 2019 / Aytu BioScience, Inc. (NASDAQ: AYTU), a specialty pharmaceutical company focused on global commercialization of novel products addressing significant medical needs, today announced that Natesto® (testosterone nasal gel) is now on formulary and covered nationwide by a leading national pharmacy benefit manager (PBM). This PBM contract provides for unrest...Jul 8, 2019First Natesto Study to Demonstrate Efficacy in Severely Hypogonadal Patients...Jul 1, 2019ENGLEWOOD, CO / ACCESSWIRE / July 1, 2019 / Aytu BioScience, Inc. (NASDAQ: AYTU), a specialty pharmaceutical company focused on commercializing novel products that address significant patient needs, announced that it has been added to the Russell Microcap® Index effective after the U.S. markets open today, July 1, 2019....Jun 25, 2019First Clinical Data Demonstrating Predictive Power of Seminal Oxidation-Reduction Potential (ORP) as a Predictor of Fertilization When Used Prior to IVF ...Jun 24, 2019ENGLEWOOD, CO / ACCESSWIRE / June 24, 2019 / Aytu BioScience, Inc. (NASDAQ: AYTU), a specialty pharmaceutical company focused on commercializing novel products that address significant patient needs, announced that the MiOXSYS® male infertility test will be featured today in a Product Theatre symposium at the 35th Annual Meeting of the European Society of Human Reproduction and Embryology (ESHRE)...Jun 18, 201911 Abstracts Featuring MiOXSYS have been Selected for Presentation at the 35th Annual Meeting of the European Society of Human Reproduction and Embryology...